fashion -WSS

fashion

author：comprehensive 2025-10-01 04:13:28 - browse：7496

Sammy Kimball for STAT

What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.

For more on what we cover, here’s the news on BridgeBio; here’s more on the Stanford president; here’s the latest on the Pfizer plant; here’s the story on Eli Lilly’s Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Group opposing PBM reform sets lobbying record

WSS

Humana cuts profit projections as Medicare Advantage costs soar

Medicare to cover more brain scans for Alzheimer’s patients

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

The surgeon had a dilemma only a Nazi medical text could resolve

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Sanofi seeks simpler, safer CRISPR sickle cell cure

hotspot

fashion

hotspot

Alkermes shareholders re

Custom gene therapy hints at new path for rare disease treatments

BioMarin wins approval for gene therapy to treat hemophilia A

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

At least 13 dead in Texas as scorching temps continue

How Medicaid coverage policies for immigrants impact new moms

The cancer drug shortage isn’t new — and neither are the solutions

Cosmetics set for new safety regulation. Why the industry is on board

Jerome Adams on the need for new antivirals for Covid

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

focus

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

EU regulator recommends expanding Mounjaro approval to obesity

Cosmetics set for new safety regulation. Why the industry is on board

Readout Newsletter: Merck, J&J, and long Covid

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Prior authorization will have to move faster under new Biden rule

hotspot

focus

explore

knowledge